USE CASE: How to Use GenAI to Write a B2B Creative Brief Six Stakeholders Can Sign for a Medical Device Manufacturer

A real-world GenAI marketing use case: how a medical device manufacturer stopped discovering its internal disagreements in round five of creative review, and started resolving them inside the B2B creative brief, where they cost nothing to fix.

AI-generated illustrative image. No real client, brand or location is depicted.

A B2B creative brief in a regulated business is not a summary of what everyone wants. It is a negotiated settlement between people who want incompatible things, and the ones that are never negotiated on paper get negotiated later, in review rounds, at the cost of the work. This is how one manufacturer moved that argument upstream.

The Context: a Launch with Six Internal Owners

A medical device manufacturer was preparing the campaign for a new product line sold to hospital groups. Six functions had a legitimate claim on the message: product marketing, sales, regulatory affairs, legal and compliance, medical affairs, and market access. Every one of them had to approve the work before it could be used by a single sales representative.

The brief that started the process was a page and a half long. It named the product, the audience, the channels and the deadline. It did not name a single point on which those six functions disagreed.

The Challenge: a Brief that Hid the Conflicts Instead of Settling Them

The disagreements were real, and they were structural rather than personal:

Regulatory affairs: the claim may go no further than the cleared indications and the evidence on file. Red line
Legal and compliance: what may be said to a clinician, and how, differs by market. Red line
Medical affairs: wants the caveats: which patients, which settings, which limits.
Product marketing: wants a proposition that separates the line from two credible competitors.
Sales: wants one sentence that survives a twelve-minute meeting on a ward.
Market access: wants the budget impact for the hospital, not the clinical story.

Some of those are trade-offs and some are constraints, and treating them as one category is where the process broke. A brief that quietly averages a regulatory red line into "let's make it punchier" does not produce a bolder campaign. It produces a fifth round of revisions, a rewrite two days before launch, and a proposition so hedged that nobody remembers it.

The part GenAI doesn't solve: Resolve the conflict on paper, not in round seven. The cost of a disagreement is not fixed; it is roughly proportional to how much work exists when it surfaces. Settled in the brief, it costs an afternoon. Settled in review, it costs the campaign's best idea, because the only thing everyone can agree on at that stage is the blandest option left standing.

The GenAI Workflow: Separating Constraints from Trade-Offs before Creative Starts

Instead of collecting stakeholder input into a shared document and hoping it cohered, the marketing lead asked each function for two things: what they need, and whether each item is a constraint – a line that cannot be traded at any price – or a priority that can be balanced against someone else's. Regulatory and legal lines came back as constraints. Almost everything else came back as a priority, which was itself the useful discovery.

GenAI was then used to do the tedious, unpopular part: read all six sets of inputs against each other, name every place where they collide, and sort those collisions into the ones that are genuinely negotiable and the ones that are already decided. It drafted one proposition that sat inside every constraint, a plain "what we cannot say" list for the creative team, and the short list of questions that still needed a human decision before anyone opened a design file.

🖥️

The GenAI prompt:

You are a B2B creative strategist working in a regulated category. Below are the inputs from each stakeholder for an upcoming campaign.

Each item is labelled CONSTRAINT (a red line that cannot be traded) or PRIORITY (a trade-off that can be balanced).
[Paste each function's inputs, labelled: regulatory, legal/compliance, medical, product marketing, sales, market access]

Audience: [the roles in the customer's buying group and what each cares about]

1. CONFLICTS: List every place where two inputs collide. For each, state which functions are involved and what exactly is incompatible.
2. SORT: Mark each conflict as NEGOTIABLE (priority vs priority) or SETTLED (anything touching a constraint). Never resolve a SETTLED conflict by softening the constraint.
3. PROPOSITION: Draft ONE proposition that sits inside every constraint and gives the negotiable conflicts a defensible balance. One proposition, not a list.
4. CANNOT SAY: Write the plain-language list of claims and phrasings the creative team must not use, and why.
5. OPEN QUESTIONS: List the decisions that still need a named human to make them before creative begins.

Flag every place where you have inferred a constraint rather than been told one, and name the function that must confirm it.

The last instruction is the one that protects the work. GenAI is non-deterministic by design, and it is agreeable by disposition: asked to make a claim more compelling, it will quietly soften a regulatory line to make the sentence work, and it will do so with complete confidence and no flag. The variable you control is not the model's restraint — it is whether the constraints going in are explicitly labelled, and whether the functions that own them confirm the output rather than an averaged version of it.

The Result: One Proposition, Agreed before the First Draft

The change is in the mechanism, not on a dashboard:

One proposition instead of six: a single line that regulatory and legal could sign without amendment, and that sales could still say out loud in a ward corridor.
A “what we cannot say” list: handed to the creative team at the start rather than discovered by them in review, which changed what got drafted in the first place.
Sign-off moved upstream: the six functions approved the brief, so review became a check on execution rather than a re-run of the strategy argument.

The visible effect was fewer, shorter review rounds. The more valuable one was that the surviving idea was recognisably the idea the team started with, rather than what remained after five rounds of collective hedging.

Recommended KPIs to Follow

A better B2B creative brief should show up in the review process, not in a brand metric. These are the metrics to watch, where the industry sits, and the direction this work pushes them.

Revision Rounds per Asset

How many times an asset goes back for changes before approval. Settling the conflicts in the brief pulls this down and, more tellingly, changes what the remaining rounds are about, execution rather than strategy.

Benchmark: The average creative review runs about eight days across three rounds, while best-in-class teams close the cycle in 24-48 hours (Ziflow, 2026). In regulated artwork, the average project runs about 6.2 revision rounds (Cway Packaging Artwork Approval Benchmark, 2026).

Time from Brief to Approved Asset

The days between a signed brief and a usable asset. Expect this to fall gradually rather than sharply, because the first cycle spends time upstream that the later cycles get back.

Benchmark: Guidance for approval cycle time: 2-3 days for low-risk assets and 5-7 for high-risk content requiring legal review; three or more revision rounds is usually a signal of a weak brief upstream (Marq, 2026).

Briefs Signed Off by Every Named Approver before Creative Starts

The share of campaigns where all functions approved the brief itself. This is the discipline metric: if it slips, the revision rounds return within a quarter.

Benchmark: No reliable public benchmark; set your own baseline and track the trend.

Your own trend, campaign to campaign, matters more than any single benchmark; the benchmark is context, not a scoreboard.

Why this Transfers

Any business where several functions must approve the same message has the same problem, regulated or not. The fix is not a longer brief. It is asking every stakeholder one extra question – is this a constraint or a preference – and settling the collisions while the only thing at stake is a document.